MBX Biosciences, Inc. Common Stock

NASDAQ:MBX

Biotechnology

Healthcare
$53.42 -1.54%

-$0.64 today

Market cap
$2.65B
Beta
0.75
P/E (TTM)
-22.0
EPS (TTM)
-$1.86
52W Low $9.43High $45.85

Volume 0.73M

Average 0.65M

MBX Pre-Tax Margin

Income before tax as a percentage of revenue.

No reported Pre-Tax Margin figures are available to summarize.

Pre-Tax Margin history

Percent of revenue · from the income statement

No Pre-Tax Margin data reported for this period type.

Pre-Tax Margin vs competitors

How MBX compares with its peers on the latest reported figures

MBX Competitors Peer median
Pre-Tax Margin for MBX and competitors
Company Period LTM level YoY 3-year change
ORMPOramed Pharmaceuticals Inc.FY20253766.2% —+5159.6 pp
ASNDAscendis Pharma A/SLTM Sep 202622.4% +57.0 pp+1099.6 pp
XERSXeris Biopharma Holdings, Inc.LTM Mar 20263.8% +25.2 pp+87.3 pp
RYTMRhythm Pharmaceuticals, Inc.LTM Sep 2026-68.5% +41.6 pp+662.9 pp
ALTAltimmune, Inc.LTM Mar 2026-253002.8% +201602.2 pp-341389.6 pp
MBXMBX Biosciences, Inc. Common StockFY2025— ——
VKTXViking Therapeutics, Inc.FY2025— ——
KLRAKailera Therapeutics, Inc.FY2025— ——
BMEABiomea Fusion, Inc.FY2025— ——
Peer median (excluding MBX) 3.8%+49.3 pp+662.9 pp

Competitors are the stored peer set for MBX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue0000
Cost of Revenue000248K
Gross Profit000(248K)
Gross Margin————
Research & Development21.4M28.53M57.42M79.16M
Selling, General & Admin3.76M6.78M10.78M18.9M
Operating Expenses25.16M35.31M68.19M98.06M
Depreciation & Amortization56K157K244K248K
EBITDA(25.71M)(32.41M)(61.68M)(86.72M)
EBITDA Margin————
Operating Income(25.16M)(35.31M)(68.19M)(98.06M)
Operating Margin————
Interest Income372K2.75M6.27M11.08M
Interest Expense374K000
Other Income / Expenses(974K)2.75M6.27M11.08M
Income Before Tax(26.14M)(32.56M)(61.92M)(86.97M)
Pre-Tax Margin————
Income Tax Expense0000
Net Income(26.14M)(32.56M)(61.92M)(86.97M)
Net Margin————
EPS (Basic)(0.82)(1.02)(1.85)(2.38)
EPS (Diluted)(0.82)(1.02)(1.85)(2.38)
Weighted Avg Shares31.85M31.85M33.39M36.51M
Weighted Avg Shares (Diluted)31.85M31.85M33.39M36.51M

MBX Biosciences, Inc. Common Stock

NASDAQ:MBX

Intrinsic Alpha fair value

Locked

Current Price

$53.42

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.